Latest Breaking News On - Charles county health - Page 5 : comparemela.com

April 13, 2021 As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen ) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.

United statesCharles countyState of marylandDiannae abneyJohnson janssenCenters for diseaseMaryland relay serviceDrug administrationAdvisory committee on immunization practicesCharles county department of healthRelay serviceCharles county healthCharles county health departmentMaryland department of healthAdvisory committeeImmunization practices